Google's life-extension biotech Calico has secured access to data held by Ancestry.com, a family tree business that sells DNA testing kits. Calico will pick through the genetic data and millions of family trees in search of contributors to long life spans and drug targets.
Automated suggestions can help pharma reps who are searching for the next step in the sales process. But more than just automatic tips, emerging intelligent data-backed suggestions can transform inexperienced or underperforming reps using the mold of a pharma's top performers.
With the clinical trial community gathering for DIA 2015, eClinical tech vendors have been rolling out releases about their new tools, hires and deals. Here we round up a batch of notable news, including a new hire at Clinical Ink, deals for DocuSign and a visit to the FDA by Nextrials.
An electronic health record-enabled data dive has turned up links between proton pump inhibitors and a 16% to 20% increase in the risk of heart attack.
Advocates of Big Data analytics often cite their craft as the antidote to gut decisions, arguing more rational, data-driven reasoning is now within the reach of businesses. At Johnson & Johnson they are putting the idea to the test, notably by digging into their employment data to support the hiring of fresh college graduates over industry veterans.
Information sharing is a major focus of the ongoing European Society for Radiotherapy & Oncology meeting in Barcelona. As expected, lots of new of data was shared and studies were presented, but the importance of actually sharing data in real time and how to do it efficiently is also being discussed.
Quest Diagnostics has teamed up with French human health research institute Inserm to pool and share BRCA1 and BRCA2 genetic data. LabCorp has signed up as the first participant in the program, giving it a sizable reach from day one.
Nature Biotechnology is encouraging authors of computational biology papers to publish their source code on GitHub as part of a company-wide drive to ensure research is reproducible. The policy is designed to counter long-standing concerns about the peer review of computation-heavy research.
Medidata has bolstered its books with two new deals. Accenture is tightening the ties between its R&D service offering and Medidata's Clinical Cloud and Rave EDC system.
The United Kingdom has wasted no time getting industry involved with its 100,000 Genomes Project. With just 3% of the sequencing work done, Genomics England has enlisted the help of a who's who of Big Pharma companies to pore over the data in search of new avenues for drug discovery.